Robert Lanza, Chief Scientific Officer at ADVANCED CELL TECHNOLOGY, INC. (ACTC), sold 600,000 shares at $0.10 ($60K) on 2010-06-21, disclosed to the SEC on 2010-06-23.
Open-market sale of $60k ACTC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.10 | 16,000 | $2K | 2.7% |
| 2 | $0.10 | 48,000 | $5K | 8.0% |
| 3 | $0.10 | 50,000 | $5K | 8.3% |
| 4 | $0.10 | 88,050 | $9K | 14.7% |
| 5 | $0.10 | 93,450 | $9K | 15.6% |
| 6 | $0.10 | 93,500 |
| $9K |
| 15.6% |
| 7 | $0.10 | 211,000 | $21K | 35.2% |
| Total | $0.10 avg | 600,000 | $60K | 100% |
| Filing → |
| ACTC | SELL | 2012-12-18 | $80K | — | Filing → |
| ACTC | SELL | 2012-08-01 | $160K | — | Filing → |
| ACTC | SELL | 2012-01-25 | $1.4M | — | Filing → |